GlaxoSmithKline Pakistan Limited (GLAXO) - PKR 372.62
Ticker: GLAXO • | Sector: PHARMACEUTICALS
RevRevenue
~ AverageRs. 61.19 B
ProfitNet Profit
✓ GoodRs. 6.54 B
EPSEPS
✗ Bad₨20.52
ROEROE
~ Average6.9%
P/EP/E
~ Average12.9x
YieldDividend Yield
✓ Good4.0%
GlaxoSmithKline Pakistan Limited has shown positive revenue growth of 23.2% over the past year. Net income has grown by 1124.0% year-over-year. The company maintains a return on equity of 6.9%.
Stock fundamentals
Key Financial Ratios
GlaxoSmithKline Pakistan Limited (GLAXO) is listed on the Pakistan Stock Exchange (PSX) under the PHARMACEUTICALS sector. This page provides real-time GLAXO share price, complete financial statements, valuation ratios, dividend history, performance charts, and stock analysis. Investors can use this data to evaluate GlaxoSmithKline Pakistan Limited's growth potential, profitability, and financial health for informed investment decisions. The latest traded price is PKR 372.62. GlaxoSmithKline Pakistan Limited has a market capitalisation of PKR 133.72M.
At a glance
- Share Price
- PKR 372.62
- Market Cap
- PKR 133.72M
- Volume
- 105,968
Frequently Asked Questions
Whether GLAXO is a good investment depends on your goals and risk tolerance. This page provides GlaxoSmithKline Pakistan Limited (GLAXO) share price, financial statements, valuation ratios (P/E, P/B, ROE), dividend yield, and performance charts on the Pakistan Stock Exchange (PSX). Use this data to evaluate growth potential, profitability, and financial health before making investment decisions.